Total Payments
$21,440
2024 Payments
$425.44
Companies
48
Transactions
1,317
Medicare Patients
1,397
Medicare Billing
$158,145
Payment Breakdown by Category
Food & Beverage$17,955 (83.7%)
Other$1,536 (7.2%)
Travel$1,203 (5.6%)
Education$595.85 (2.8%)
Consulting$150.00 (0.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $17,955 | 1,301 | 83.7% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1,536 | 3 | 7.2% |
| Travel and Lodging | $1,203 | 3 | 5.6% |
| Education | $595.85 | 9 | 2.8% |
| Consulting Fee | $150.00 | 1 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Supernus Pharmaceuticals, Inc. | $5,272 | 248 | $0 (2021) |
| Teva Pharmaceuticals USA, Inc. | $2,718 | 152 | $0 (2024) |
| EMD Serono, Inc. | $1,849 | 181 | $0 (2024) |
| UCB, Inc. | $1,437 | 97 | $0 (2024) |
| Biogen, Inc. | $1,392 | 89 | $0 (2024) |
| Amgen Inc. | $1,329 | 107 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $1,039 | 65 | $0 (2023) |
| ABBVIE INC. | $642.34 | 35 | $0 (2024) |
| GENZYME CORPORATION | $619.22 | 42 | $0 (2023) |
| Lilly USA, LLC | $453.60 | 24 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $425.44 | 20 | Biogen, Inc. ($159.68) |
| 2023 | $1,511 | 88 | Teva Pharmaceuticals USA, Inc. ($303.13) |
| 2022 | $2,165 | 134 | Amgen Inc. ($369.22) |
| 2021 | $2,670 | 174 | Teva Pharmaceuticals USA, Inc. ($362.75) |
| 2020 | $2,552 | 202 | Supernus Pharmaceuticals, Inc. ($656.19) |
| 2019 | $2,916 | 243 | Teva Pharmaceuticals USA, Inc. ($536.40) |
| 2018 | $3,064 | 229 | Teva Pharmaceuticals USA, Inc. ($577.95) |
| 2017 | $6,137 | 227 | Supernus Pharmaceuticals, Inc. ($3,557) |
All Payment Transactions
1,317 individual payment records from CMS Open Payments — Page 1 of 53
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/25/2024 | Biogen, Inc. | TYSABRI (Biological), VUMERITY | Food and Beverage | In-kind items and services | $25.93 | General |
| Category: Neurology | ||||||
| 05/21/2024 | Biogen, Inc. | SPINRAZA (Biological) | Food and Beverage | In-kind items and services | $20.46 | General |
| Category: Neurology | ||||||
| 05/14/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $41.66 | General |
| Category: Central Nervous System | ||||||
| 05/07/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $14.47 | General |
| Category: Neuropsychiatry | ||||||
| 05/02/2024 | Biogen, Inc. | AVONEX (Biological), VUMERITY | Food and Beverage | In-kind items and services | $24.47 | General |
| Category: Neurology | ||||||
| 04/23/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $14.26 | General |
| 04/16/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $24.36 | General |
| Category: NEUROSCIENCE | ||||||
| 04/04/2024 | Biogen, Inc. | VUMERITY (Drug) | Food and Beverage | In-kind items and services | $15.25 | General |
| Category: Neurology | ||||||
| 04/03/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $36.46 | General |
| Category: Central Nervous System | ||||||
| 03/28/2024 | Biogen, Inc. | AVONEX (Biological), VUMERITY | Food and Beverage | In-kind items and services | $18.67 | General |
| Category: Neurology | ||||||
| 03/26/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $18.13 | General |
| 03/19/2024 | Biogen, Inc. | SPINRAZA (Biological) | Food and Beverage | In-kind items and services | $27.54 | General |
| Category: Neurology | ||||||
| 03/12/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $20.79 | General |
| Category: PAIN | ||||||
| 03/05/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $16.21 | General |
| 02/13/2024 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $15.83 | General |
| Category: Neurology | ||||||
| 02/06/2024 | JAZZ PHARMACEUTICALS INC. | EPIDIOLEX (Drug) | Food and Beverage | In-kind items and services | $16.37 | General |
| Category: NEUROLOGY | ||||||
| 01/30/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $14.42 | General |
| Category: Neuropsychiatry | ||||||
| 01/16/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $15.58 | General |
| 01/09/2024 | Biogen, Inc. | TYSABRI (Biological), VUMERITY | Food and Beverage | In-kind items and services | $27.36 | General |
| Category: Neurology | ||||||
| 01/04/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $17.22 | General |
| Category: NEUROSCIENCE | ||||||
| 12/12/2023 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $39.87 | General |
| Category: Central Nervous System | ||||||
| 12/12/2023 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $7.99 | General |
| Category: Central Nervous System | ||||||
| 12/07/2023 | EMD Serono, Inc. | MAVENCLAD (Drug) | Food and Beverage | Cash or cash equivalent | $20.87 | General |
| Category: Neurology | ||||||
| 12/07/2023 | EMD Serono, Inc. | MAVENCLAD (Drug) | Food and Beverage | Cash or cash equivalent | $2.69 | General |
| Category: Neurology | ||||||
| 12/07/2023 | EMD Serono, Inc. | MAVENCLAD (Drug) | Food and Beverage | Cash or cash equivalent | $2.43 | General |
| Category: Neurology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 269 | 333 | $134,425 | $27,587 |
| 2022 | 7 | 298 | 362 | $130,570 | $32,421 |
| 2021 | 7 | 426 | 548 | $208,285 | $52,745 |
| 2020 | 7 | 404 | 549 | $176,040 | $45,392 |
Total Patients
1,397
Total Services
1,792
Medicare Billing
$158,145
Procedure Codes
26
All Medicare Procedures & Services
26 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 90 | 135 | $43,875 | $9,551 | 21.8% |
| 95912 | Nerve conduction, 11-12 studies | Office | 2023 | 32 | 32 | $38,400 | $5,609 | 14.6% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2023 | 43 | 44 | $35,200 | $5,013 | 14.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 62 | 77 | $11,550 | $4,845 | 41.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 42 | 45 | $5,400 | $2,570 | 47.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 99 | 134 | $20,100 | $10,489 | 52.2% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 84 | 112 | $36,400 | $8,445 | 23.2% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2022 | 48 | 49 | $39,200 | $6,016 | 15.3% |
| 95912 | Nerve conduction, 11-12 studies | Office | 2022 | 19 | 19 | $22,800 | $3,741 | 16.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 19 | 19 | $5,510 | $1,854 | 33.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 18 | 18 | $2,160 | $983.05 | 45.5% |
| 95908 | Nerve conduction, 3-4 studies | Office | 2022 | 11 | 11 | $4,400 | $892.75 | 20.3% |
| 95886 | Needle measurement and recording of electrical activity of muscles of arm or leg complete study | Office | 2021 | 120 | 181 | $58,825 | $14,163 | 24.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 127 | 182 | $27,300 | $13,642 | 50.0% |
| 95912 | Nerve transmission studies, 11-12 studies | Office | 2021 | 48 | 48 | $57,600 | $9,732 | 16.9% |
| 95910 | Nerve transmission studies, 7-8 studies | Office | 2021 | 56 | 57 | $45,600 | $8,158 | 17.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 40 | 45 | $5,400 | $3,028 | 56.1% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 24 | 24 | $6,960 | $2,909 | 41.8% |
| 95909 | Nerve transmission studies, 5-6 studies | Office | 2021 | 11 | 11 | $6,600 | $1,114 | 16.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 153 | 249 | $37,350 | $16,343 | 43.8% |
| 95886 | Needle measurement and recording of electrical activity of muscles of arm or leg complete study | Office | 2020 | 87 | 130 | $42,250 | $9,725 | 23.0% |
| 95912 | Nerve transmission studies, 11-12 studies | Office | 2020 | 30 | 30 | $36,000 | $5,831 | 16.2% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 56 | 56 | $16,240 | $5,814 | 35.8% |
| 95910 | Nerve transmission studies, 7-8 studies | Office | 2020 | 41 | 41 | $32,800 | $4,802 | 14.6% |
| 95909 | Nerve transmission studies, 5-6 studies | Office | 2020 | 13 | 13 | $7,800 | $1,473 | 18.9% |
About Dr. Daniel Freeman, MD
Dr. Daniel Freeman, MD is a Neurology healthcare provider based in Jackson, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/01/2006. The National Provider Identifier (NPI) number assigned to this provider is 1336107374.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Freeman, MD has received a total of $21,440 in payments from pharmaceutical and medical device companies, with $425.44 received in 2024. These payments were reported across 1,317 transactions from 48 companies. The most common payment nature is "Food and Beverage" ($17,955).
As a Medicare-enrolled provider, Freeman has provided services to 1,397 Medicare beneficiaries, totaling 1,792 services with total Medicare billing of $158,145. Data is available for 4 years (2020–2023), covering 26 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Jackson, MI
- Active Since 05/01/2006
- Last Updated 11/12/2009
- Taxonomy Code 2084N0400X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1336107374
Products in Payments
- TROKENDI XR (Drug) $5,272
- Aimovig (Biological) $1,232
- Briviact (Drug) $1,050
- TYSABRI (Biological) $787.75
- Rebif (Biological) $600.96
- AJOVY (Drug) $561.77
- AUSTEDO (Drug) $551.23
- UBRELVY (Drug) $521.78
- AJOVY (Biological) $480.98
- AUBAGIO (Drug) $471.71
- EMGALITY (Drug) $410.99
- APTIOM (Drug) $345.37
- Mavenclad (Drug) $337.44
- COPAXONE (Drug) $333.46
- Vimpat (Drug) $328.74
- Mavenclad (Biological) $327.43
- Fycompa (Drug) $318.83
- KESIMPTA (Drug) $314.04
- GILENYA (Drug) $302.34
- NURTEC ODT (Drug) $271.82
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Jackson
Wendell Helveston, Md, MD
Neurology — Payments: $862,844
Neurology $862,844
Dr. John Wald, M.d, M.D
Neurology — Payments: $530,414
Neurology $530,414
Dr. Rajesh Sharma, M.d., Ph.d., M.b.a, M.D., PH.D., M.B.A
Neurology — Payments: $152,354
Neurology $152,354
Dr. Patrick Weldon, M.d, M.D
Neurology — Payments: $75,924
Neurology $75,924
Tiffany Scarff, M.d, M.D
Neurology — Payments: $50,276
Neurology $50,276
Mitchell Myers, M.d, M.D
Neurology — Payments: $46,488
Neurology $46,488